Centro de Medicina de Reabilitação de Alcoitão
The main purpose of the first study was to evaluate the INSIGHT System (a combined socket interior 3D scanner, patient wearable, and tablet app) and its performance on residual limb-socket fittings – in particular to test how the efficiency of the fitting process could be improved, and how comfortable and usable the final prosthesis was for the patient.
To reach this objective it was important to garner quantitative feedback from the clinicians prescribing and fitting the prosthesis, technicians designing and building the prosthesis, and lower limb patients wearing and using the prosthesis within clinic and while performing their activities of daily living (post-fitting).
The majority of patients achieved a satisfactory socket in just 1 visit with a quarter of patients requiring 2 visits. The technician’s evaluation time using INSIGHT was on average half that of using traditional evaluation methods. The utility and acceptability of the INSIGHT System was positively evaluated by both patients and technicians, as assessed by opinion questionnaires.
De La Torre O&P, Pittsburgh, PA
Prosthetics & Orthotic Associates, Middletown, NY.
The main purpose of this study is to deeper evaluate the INSIGHT System (a combined socket interior 3D scanner, patient wearable, and iPad app) and its performance on residual limb-socket fittings. This study is based on a previously successful independent study, led by Principal Investigator Natália Ramos M.D. at the Centro de Medicina de Reabilitação de Alcoitão in Portugal.
This study is currently running at De La Torre O&P, Pittsburgh, PA, and Prosthetics & Orthotic Associates, Middletown, NY. It will expand on the previous study’s objectives: testing the efficiency of the fitting process; how comfortable and usable the final prosthesis; and financial analysis into the commercial benefit of the INSIGHT system for OAP clinics. The study will use clinically recognised benchmark tests to gather quantitative feedback from the clinicians, technicians and patients.
The results of the study will be available for the first time at the AOPA conference in San Diego in 2019.
THIS STUDY IS ONGOING